All Search Results
News Releases
Aug 26, 2025, 08:34 ET OODAcon 2025: Accelerating Disruptive Technologies
scenario-driven update on the world's most urgent risks.Biotech Warfare and Biosecurity in the Age of AI: Navigating the risks of synthetic biology and dual-use research.Art and Privacy in the Age of AI: Protecting civil liberties and resilience amid ubiquitous surveillance.Moving
More news about: OODA LLC
Aug 21, 2025, 08:30 ET AI in Molecular Biology: Revolutionizing the Future of Biotech, Upcoming Webinar Hosted by Xtalks
simplify research processes in biotechnology and life sciences. Attendees will learn how accelerated innovation facilitates breakthroughs in synthetic biology, drug discovery, gene therapy and other cutting-edge fields. The featured speaker will share how data-driven decisions empower scientists with
More news about: Xtalks
Aug 20, 2025, 10:15 ET Human Microbiome Market worth $7.09 billion by 2031 with 31.0% CAGR | MarketsandMarkets™
different stages of life or health needs. The microbiome innovation of IFF is supported by ongoing collaborations and a broader portfolio in synthetic biology, enabling the development of functional ingredients across consumer and health product categories. For more information,
More news about: MarketsandMarkets
Aug 20, 2025, 08:32 ET Quintara Biosciences Launches Whole Plasmid Sequencing - Express (WPS-Express) Across Four U.S. Sites
length or data quality. Combined with localized logistics support, the service is ideal for fast-paced research settings in molecular cloning, synthetic biology, and antibody discovery. Quintara Biosciences is a nationwide provider of genomics and molecular biology services, offering sequencing,
More news about: Quintara Biosciences
Aug 20, 2025, 08:01 ET Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
